These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38479808)

  • 21. Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients.
    Kubo S; Nakayamada S; Yoshikawa M; Miyazaki Y; Sakata K; Nakano K; Hanami K; Iwata S; Miyagawa I; Saito K; Tanaka Y
    Arthritis Rheumatol; 2017 Oct; 69(10):2029-2037. PubMed ID: 28605137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Serum Cell-Free microRNA Expression Profile in MCTD, SLE, SSc, and RA Patients.
    Stypinska B; Wajda A; Walczuk E; Olesinska M; Lewandowska A; Walczyk M; Paradowska-Gorycka A
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can SLE classification rules be effectively applied to diagnose unclear SLE cases?
    Mesa A; Fernandez M; Wu W; Narasimhan G; Greidinger EL; Mills DK
    Lupus; 2017 Feb; 26(2):150-162. PubMed ID: 27353506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
    Mitsuo A; Morimoto S; Nakiri Y; Suzuki J; Kaneko H; Tokano Y; Tsuda H; Takasaki Y; Hashimoto H
    Rheumatology (Oxford); 2006 Dec; 45(12):1477-84. PubMed ID: 16638798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody].
    Miyamae T; Ito S; Machida H; Ozawa R; Higuchi R; Nakajima S; Imagawa T; Nakamura T; Mori M; Aihara Y; Ohshige K; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):405-14. PubMed ID: 18974625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
    Bakri Hassan A; Rönnelid J; Gunnarsson I; Karlsson G; Berg L; Lundberg I
    J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan.
    Kotajima L; Aotsuka S; Sumiya M; Yokohari R; Tojo T; Kasukawa R
    J Rheumatol; 1996 Jun; 23(6):1088-94. PubMed ID: 8782145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the T-G-CT-G SNRNP70 haplotype another proof that mixed connective tissue disease is distinct from systemic lupus erythematosus and systemic sclerosis? A novel gene variant in SNRNP70 gene.
    Paradowska-Gorycka A; Wajda A; Stolarek I; Felis-Giemza A; Walczyk M; Nałecz-Janik J; Olesińska M
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):32-40. PubMed ID: 31573470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
    Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological assessment in mixed connective tissue disease: comparison with systemic lupus erythematosus.
    Nowicka-Sauer K; Czuszynska Z; Majkowicz M; Smolenska Z; Jarmoszewicz K; Olesinska M; Siebert J
    Lupus; 2012 Aug; 21(9):927-33. PubMed ID: 22433916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus.
    Ruuska P; Hämeenkorpi R; Forsberg S; Julkunen H; Mäkitalo R; Ilonen J; Tiilikainen A
    Ann Rheum Dis; 1992 Jan; 51(1):52-5. PubMed ID: 1540038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of systemic and thyroid autoimmune diseases.
    Biró E; Szekanecz Z; Czirják L; Dankó K; Kiss E; Szabó NA; Szucs G; Zeher M; Bodolay E; Szegedi G; Bakó G
    Clin Rheumatol; 2006 Mar; 25(2):240-5. PubMed ID: 16247581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
    Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
    J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease.
    Takasaki Y; Yamanaka K; Takasaki C; Matsushita M; Yamada H; Nawata M; Matsudaira R; Ikeda K; Kaneda K; Hashimoto H
    Mod Rheumatol; 2004; 14(5):367-75. PubMed ID: 17143695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian population.
    Maldonado ME; Perez M; Pignac-Kobinger J; Marx ET; Tozman EM; Greidinger EL; Hoffman RW
    J Rheumatol; 2008 Mar; 35(3):429-37. PubMed ID: 18260175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed Connective Tissue Disease: The Two Cases Representing the Range of this Illness.
    Parrey AH; Koka M; Ismail M
    Curr Rheumatol Rev; 2024; 20(5):569-573. PubMed ID: 38314593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lifestyle and other related factors for the development of mixed connective tissue disease among Japanese females in comparison with systemic lupus erythematosus.
    Washio M; Fujii T; Kuwana M; Kawaguchi Y; Mimori A; Horiuchi T; Tada Y; Takahashi H; Mimori T;
    Mod Rheumatol; 2014 Sep; 24(5):788-92. PubMed ID: 24499377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detecting anti-cyclic citrullinated peptide antibody in patients with connective tissue diseases].
    Yin G; Cen XM; Yang M; Xie QB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):374-7. PubMed ID: 21827002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial aspects of mixed connective tissue disease (MCTD). I. Occurrence of systemic lupus erythematosus in another member in two families and aggregation of MCTD in another family.
    Ramos-Niembro F; Alarcon-Segovia D
    J Rheumatol; 1978; 5(4):433-40. PubMed ID: 310886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.